Interaction of mutant hepatitis B X protein with p53 tumor suppressor protein affects both transcription and cell survival

Molecular Carcinogenesis

Volumn 50, Issue 12, 2011, Pages 972-980

  Iyer, Shoba ^a   Groopman, John D ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Hepatitis B virus; Hepatitis B virus X protein; Hepatocellular carcinoma; P53; Risk factor

Indexed keywords

HEPATITIS B VIRUS X PROTEIN; PROTEIN P53;

ARTICLE; CANCER INHIBITION; CELL ASSAY; CELL GROWTH; CELL STRAIN HEPG2; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CODON; COLONY FORMATION; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

AMINO ACID SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; HEK293 CELLS; HEPATITIS B VIRUS; HUMANS; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

HEPATITIS B VIRUS;

EID: 80051932038     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20767     Document Type: Article

References (40)

1. Garcia M, Jemal A, Ward E, et al. Global Cancer Facts & Figures 2007. Am Cancer Soc 2007; 18.
2. Thomas M, Zhu A. Hepatocellular carcinoma: The need for progress. J Clin Oncol 2005;23:2892-2899.
3. Wang X, Forrester K, Yeh H, Feitelson M, Gu J-R, Harris C. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA 1994;91:2230-2234.
4. Elmore L, Hancock A, Chang S-F, et al. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl Acad Sci USA 1997;94:14707-14712.
5. Feitelson M, Ranganathan P, Clayton M, Zhang S. Partial characterization of the woodchuck tumor suppressor, p53, and its interaction with woodchuck hepatitis virus X antigen. Oncogene 1997;1997:3.
6. Takada S, Kaneniwa N, Tsuchida N, Koike K. Cytoplasmic retention of the p53 tumor suppressor gene product is observed in the hepatitis B virus gene-transfected cells. Oncogene 1997;15:1895-1901.
7. Wang X, Gibson M, Vermeulen W, et al. Abrogration of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res 1995;55:6012-6016.
8. Lee S, Rho H. Transcriptional repression of the human p53 gene by hepatitis B viral X protein. Oncogene 2000;19:468-471.
9. Cheng A, Yu J, Lai P, Chan H, Sung J. COX-2 mediates hepatitis B virus X protein abrogation of p53-induced apoptosis. Biochem Biophys Res Commun 2008;374:175-180.
10. Ueda H, Ullrich S, Gangemi D, et al. Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet 1995;9:41-47.
11. Hollstein M, Sidransky D, Vogelstein B, Harris C. p53 mutations in human cancers. Science 1991;253:49-53.
12. Tong M, Blatt L, Kao J-H, Cheng J, Corey W. Basal core promoter T1762/A1764 and precore 1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: A comparison with chronic carriers. Liver Int 2007;27:1356-1363.
13. Fang Z-L, Sabin C, Dong B-Q, et al. HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: A prospective study. Am J Gastroenterol 2008;103:2254-2262.
14. Yang H-I, Yeh S-H, Chen P-J, et al. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst 2008;100:1134-1143.
15. Yuan J-M, Ambinder A, Fan Y, Gao Y-T, Yu M, Groopman J. Prospective evaluation of hepatitis B 1762T/1764A mutations on hepatocellular carcinoma development in Shanghai, China. Cancer Epidemiol Biomark Prev 2009;18:590-594.
16. Buckwold V, Xu Z, Chen M, Yen T, Ou J-H. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol 1996;70:5845-5851.
17. Buckwold V, Xu Z, Yen T, Ou J-H. Effects of a frequent double-nucleotide basal core promoter mutation and its putative single-nucleotide precursor mutations on hepatitis B virus gene expression and replication. J Gen Virol 1997;78:2055-2065.
18. Zheng Y, Li J, Ou J-H. Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein. J Virol 2004;78:6908-6914.
19. Lin Y, Nomura T, Yamashita T, Dorjsuren D, Tang H, Murakami S. The transactivating and p53-interacting functions of hepatitis B virus X protein are mutually interfering but distinct. Cancer Res 1997;57:5137-5142.
20. Sells M, Chen M, Acs G. Production of hepatitis B virus in HepG2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA 1987;87:1005-1009.
21. Radhakrishnan S, Gierut J, Gartel A. Multiple alternate p21 transcripts are regulated by p53 in human cells. Oncogene 2006;25:3264-3270.
22. Bunz F, Dutriaux A, Lengauer C, et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998;282:1497-1501.
23. Hirschman S, Price P, Garfinkel E, Christman J, Acs G. Expression of cloned hepatitis B virus DNA in human cell cultures. Proc Natl Acad Sci 1980;77:5507-5511.
24. Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR, Harris CC. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA 1994;91:2230-2234.
25. Lees-Miller S, Sakaguchi K, Ullrich S, Appella E, Anderson C. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol Cell Biol 1992;12:5041-5049.
26. Fiscella M, Ullrich S, Zambrano N, et al. Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression. Oncogene 1993;8:1519-1528.
27. Kim H, Lee H, Yun Y. X-gene product of hepatitis B virus induces apoptosis in liver cells. J Biol Chem 1998;273:381-385.
28. Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D, Brechot C. Hepatitis B virus mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene 1999;18:4848-4859.
29. Kuang SY, Lekawanvijit S, Maneekarn N, et al. Hepatitis B 1762 T /1764 A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand. Cancer Epidemiol Biomark Prev 2005;14:380-384.
30. Yang H-I, Yeh S-H, Chen P-J, et al. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl Cancer Inst 2008;100:1134-1143.
31. Lee A, Ren J, Wong E-T, Ban K, Lee L, Lee C. The hepatitis B virus X protein sensitizes HepG2 cells to UV light-induced DNA damage. J Biol Chem 2005;280:33525-33535.
32. Colgrove R, Simon G, Ganem D. Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication. J Virol 1989;63:4019-4026.
33. Bouchard M, Wang L, Schneider R. Activation of focal adhesion kinase by hepatitis B virus HBx protein: Multiple functions in viral replication. J Virol 2006;80:4406-4414.
34. Sanz-Cameno P, Martin-Vilchez S, Lara-Pezzi E, et al. Hepatitis B virus promotes angiopoietin-2 expression in liver tissue. Am J Pathol 2006;169:1215-1222.
35. Mathonnet G, Lachance S, Alaoui-Jamali M, Drobetsky E. Expression of hepatitis B virus X oncoprotein inhibits transcription-coupled nucleotide excision repair in human cells. Mutat Res 2004;554:305-318.
36. Doitsh G, Shaul Y. HBV transcription repression in response to genotoxic stress is p53-dependent and abrogated by pX. Oncogene 1999;18:7506-7513.
37. Wajapayee N, Serra R, Zhu X, Mahalingam M, Green M. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 2008;132:363-374.
38. Yu H, McDaid R, Lee J, et al. The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes. Am J Pathol 2009;174:2367-2377.
39. Jiang W, Wang X, Unger T, et al. Cooperation of tumor-derived HBx mutants and p53-249ser mutant in regulating cell proliferation, anchorage-independent growth and aneuploidy in a telomerase-immortalized normal human hepatocyte-derived cell line. Int J Cancer 2010;127:1011-1020.
40. Henkler F, Hoare J, Waseem N, et al. Intracellular localization of the hepatitis B virus HBx protein. J Gen Virol 2001;82:871-882.